These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12898459)

  • 21. Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children.
    Coutant R; Boux de Casson F; Rouleau S; Douay O; Mathieu E; Audran M; Limal JM
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5805-12. PubMed ID: 11739442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone.
    Olney RC; Prickett TC; Yandle TG; Espiner EA; Han JC; Mauras N
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4294-8. PubMed ID: 17684048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.
    Coutant R; de Casson FB; Rouleau S; Douay O; Mathieu E; Gatelais F; Bouhours-Nouet N; Voinot C; Audran M; Limal JM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6185-92. PubMed ID: 15579776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.
    Johansson JO; Oscarsson J; Bjarnason R; Bengtsson BA
    Metabolism; 1996 Mar; 45(3):362-9. PubMed ID: 8606645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
    Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.
    Mauras N; George D; Evans J; Milov D; Abrams S; Rini A; Welch S; Haymond MW
    Metabolism; 2002 Jan; 51(1):127-35. PubMed ID: 11782884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
    Roemmich JN; Clark PA; Lusk M; Friel A; Weltman A; Epstein LH; Rogol AD
    Int J Obes Relat Metab Disord; 2002 May; 26(5):701-9. PubMed ID: 12032756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone (GH) regulation of circulating insulin-like growth factor-I levels during sexual maturation of the GH-deficient dwarf (dw/dw) male rat.
    Crawford BA; Dobbie P; Bass JJ; Lewitt MS; Baxter RC; Handelsman DJ
    J Endocrinol; 1994 Jun; 141(3):393-401. PubMed ID: 7520929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
    Nielsen S; Møller N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
    JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
    Mauras N; Martha PM; Quarmby V; Haymond MW
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E628-33. PubMed ID: 9142884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of testosterone on somatomedin-C concentrations in prepubertal boys.
    Parker MW; Johanson AJ; Rogol AD; Kaiser DL; Blizzard RM
    J Clin Endocrinol Metab; 1984 Jan; 58(1):87-90. PubMed ID: 6537787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial.
    Giannoulis MG; Jackson N; Shojaee-Moradie F; Sonksen PH; Martin FC; Umpleby AM
    Growth Horm IGF Res; 2006; 16(5-6):308-17. PubMed ID: 17029996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian hyperandrogenism is associated with insulin resistance to both peripheral carbohydrate and whole-body protein metabolism in postpubertal young females: a metabolic study.
    Mauras N; Welch S; Rini A; Haymond MW
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1900-5. PubMed ID: 9626116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
    Mauras N; Beaufrere B
    J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.